265 related articles for article (PubMed ID: 33919851)
1. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
Marini F; Giusti F; Tonelli F; Brandi ML
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
[TBL] [Abstract][Full Text] [Related]
2. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?
Ramamoorthy B; Nilubol N
Surg Oncol Clin N Am; 2023 Apr; 32(2):315-325. PubMed ID: 36925188
[TBL] [Abstract][Full Text] [Related]
3. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging therapies for PNETs in patients with or without MEN1.
Frost M; Lines KE; Thakker RV
Nat Rev Endocrinol; 2018 Apr; 14(4):216-227. PubMed ID: 29449689
[TBL] [Abstract][Full Text] [Related]
5. Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches.
Stevenson M; Lines KE; Thakker RV
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):525-548. PubMed ID: 30098714
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
8. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
Komminoth P
Diagn Mol Pathol; 1999 Sep; 8(3):107-12. PubMed ID: 10565680
[TBL] [Abstract][Full Text] [Related]
9. Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours.
Jiang X; Cao Y; Li F; Su Y; Li Y; Peng Y; Cheng Y; Zhang C; Wang W; Ning G
Nat Commun; 2014 Dec; 5():5809. PubMed ID: 25517963
[TBL] [Abstract][Full Text] [Related]
10. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
11. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
Shen HC; He M; Powell A; Adem A; Lorang D; Heller C; Grover AC; Ylaya K; Hewitt SM; Marx SJ; Spiegel AM; Libutti SK
Cancer Res; 2009 Mar; 69(5):1858-66. PubMed ID: 19208834
[TBL] [Abstract][Full Text] [Related]
12. Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 Centimeters.
Faggiano A; Modica R; Lo Calzo F; Camera L; Napolitano V; Altieri B; de Cicco F; Bottiglieri F; Sesti F; Badalamenti G; Isidori AM; Colao A
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31586182
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.
Iyer S; Agarwal SK
J Mol Endocrinol; 2018 Jul; 61(1):R13-R24. PubMed ID: 29615472
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
Thakker RV
Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.
Chiloiro S; Lanza F; Bianchi A; Schinzari G; Brizi MG; Giampietro A; Rufini V; Inzani F; Giordano A; Rindi G; Pontecorvi A; De Marinis L
Endocrine; 2018 May; 60(2):362-367. PubMed ID: 28567607
[TBL] [Abstract][Full Text] [Related]
19. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
20. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
